Thermal breast imaging developer Computerized Thermal Imaging has received a medical device license from Health Canada to market its breast cancer imaging system (BCS2100) in that country.
BCS2100 uses infrared thermal imaging as an adjunct to assist in the early detection and characterization of breast cancer. The noninvasive process requires no breast compression, electrical current, or patient exposure to radiation, according to the Ogden, UT-based developer.
In related news, the company said it believes its three Canadian distributors are looking forward to adding BCS2100 to the leasing program recently provided by a $500 million commitment from Associated International Leasing. The new leasing program will allow practitioners to lease the BCS2100 on a monthly basis.
By AuntMinnie.com staff writersApril 27, 2004
Related Reading
Thermal firm CTI delisted from AMEX, moves to OTCBB
CTI class action suit dismissed, April 23, 2003
CTI trims loss, ups revenue in Q2, February 20, 2003
FDA nixes Computerized Thermal Imaging system, January 28, 2003
Thermal breast-imaging device fails to win FDA advisors' support, December 11, 2002
Copyright © 2004 AuntMinnie.com
